UNSPSC 85819203: Transfusion of autologous cord blood stem cells into peripheral artery, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous cord blood stem cells into peripheral artery, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30250X0

UNSPSC 85819203 (Commodity) — Transfusion of autologous cord blood stem cells into peripheral artery, open approach — shows no relevant recent state and local procurement activity. The six most recent opportunities tagged under this code span occupational medical surveillance, independent medical evaluations for pension disability determinations, surgical benefit carve-out programs, emergency and inpatient hospital services for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these solicitations involve cord blood stem cell transfusion or autologous cell therapy of any kind. The code appears to be misapplied across a broad range of health and human services contracting that falls outside its medical-procedure-specific scope.

State and local buying offices issuing under this code include county health systems (Santa Clara), city retirement boards (Phoenix), municipal employee health programs (Long Beach), state transportation departments (Washington), county juvenile justice systems (Harris County), and county human resources divisions (Collier County). Recent opportunities range from $750,000 five-year services contracts for medical record review and independent examinations to estimated $8.7 million annual pharmacy benefit management programs. Without opportunities genuinely addressing cord blood stem cell transfusion services, meaningful geographic spread or representative procurement patterns cannot be identified from the current activity stream.